EphrinB2 alleviates tubulointerstitial fibrosis in diabetic kidney disease. [PDF]
Ni L +7 more
europepmc +1 more source
Sodium-glucose cotransport inhibitors: mechanisms, metabolic effects and implications for the treatment of diabetic patients with chronic kidney disease: FIGURE 1: [PDF]
George Vlotides, Peter R. Mertens
openalex +1 more source
Programmed Cell Death in Diabetic Kidney Disease: Mechanisms and Therapeutic Targeting. [PDF]
Tang S +9 more
europepmc +1 more source
Nondiabetic kidney disease in type 2 diabetic patients: A single center experience
Uttara Das +3 more
openalex +1 more source
Prevalence of Chronic Kidney Disease and Associated Risk Factors among Diabetic Patients in Southern Ethiopia [PDF]
Temesgen Fiseha
openalex +1 more source
Inhibition of Activin A Signaling by Follistatin Alleviates Diabetic Kidney Disease Burden. [PDF]
Rangel ÉB.
europepmc +1 more source
Renal microcirculation and mechanisms in diabetic kidney disease. [PDF]
Hang X +7 more
europepmc +1 more source
Social risk profiles and diabetic kidney disease: prevalence and mortality in US adults. [PDF]
Lin Z +5 more
europepmc +1 more source
Preventing the Progression of Diabetic Kidney Disease [PDF]
Sheikh Salahuddin Ahmed
openalex +1 more source
Performance of novel biomarkers for prediction of diabetic kidney disease in patients with diabetes mellitus. [PDF]
Zou LX, Hou ZL, Qian CH, Wang X, Sun L.
europepmc +1 more source

